492 Results (Page 18 of 20)
US Markets Research Reports
US Healthcare Financial Analytics Market Analysis
The US Healthcare Financial Analytics market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4.8% from 2022 to 2030 and will reach $xx Bn in 2030. The market is segmented by type, component, and deployment. The US Healthcare Financial Analytics market will grow due to adoption of electronic health records (EHRs). The key market players are OptumInsight, McKesson Corporation, Cerner Corporation, IBM Corporation, and others.
US Cardiac Surgery Instruments Market Analysis
The US cardiac surgery instruments market is projected to grow from $0.9 Bn in 2022 to $1.2 Bn by 2030, registering a CAGR of 4.6% during the forecast period of 2022-30. This growth is primarily due to an increasing number of cardiac surgeries, especially in the elderly population, and the adoption of advanced surgical instruments. The market is highly competitive, with several established players including B. Braun Melsungen AG, CONMED Corporation, Johnson & Johnson Services, Inc., Medline Industries, Inc., and Stryker Corporation. These companies offer a wide range of cardiac surgery instruments and compete on the basis of product quality, innovation, and pricing.
US Teleradiology Market Analysis
The US Teleradiology market size was valued at $995 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.7% from 2022 to 2030 and will reach $2088 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The US teleradiology market will grow due to technological advancements in cloud computing telecommunication and image transfer technologies have made it easier to transmit radiological images remotely. The key market players are vRad, Radiology Partners, Nighthawk Radiology Services, and others.
US Medical Devices Market Analysis
The US medical devices market is projected to grow from $207 Bn in 2022 to $275 Bn by 2030, registering a CAGR of 3.60% during the forecast period of 2022-30. As the US population continues to age, the demand for medical devices is expected to increase. Older adults are more likely to have chronic health conditions that require monitoring and treatment, and medical devices can play a key role in managing these conditions. Some of the key players in the US medical device market include companies like Medtronic, Johnson & Johnson, GE Healthcare, and Abbott Laboratories, among others.
US Oncology Therapeutics Market Analysis
The US oncology therapeutics market is projected to grow from $83 Bn in 2022 to $172 Bn by 2030, registering a CAGR of 9.6% during the forecast period of 2022-30. The development of new and innovative cancer treatments, such as immunotherapies and targeted therapies, is driving the growth of the oncology therapeutics market. This market is highly competitive, with many large pharmaceutical companies and biotech companies competing for market share. Some of the major players in the market include Roche, Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, AstraZeneca, and Johnson & Johnson
US Lung Cancer Therapeutics Market Analysis
The US lung cancer therapeutics market is projected to grow from $4 Bn in 2022 to $6.5 Bn by 2030, registering a CAGR of 6.3% during the forecast period of 2022–30. According to the American Cancer Society, lung cancer is the leading cause of cancer deaths in the US for both men and women. In 2022, it is estimated that there will be about 235,760 new cases of lung cancer and 131,880 deaths from the disease in the US. Some of the key players in the US lung cancer therapeutics market include AstraZeneca, Pfizer, Roche, Merck, and Bristol-Myers Squibb, among others.
US Patient Engagement Solutions Market Analysis
The US patient engagement solutions market is projected to grow from $7.14 Bn in 2022 to $15.54 Bn by 2030, registering a CAGR of 10.2% during the forecast period of 2022 - 2030. The main factors driving the growth would be increased use of mobile and digital technologies, growing focus on value-based care, rising healthcare costs and government support and initiatives. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include Allscripts, Cerner Corporation, Symphony Care, GetWellNetwork, Athena Health, CureMD Healthcare, Medhost, Mckesson and Humana.
US Artificial Intelligence (AI) in Diagnostics Market Analysis
The US Artificial Intelligence (AI) in the diagnostics market is projected to grow from $0.42 Bn in 2022 to $4.11 Bn by 2030, registering a CAGR of 33% during the forecast period of 2022 - 2030. The market will be driven by the growing number of AI-based diagnostic companies and supportive government initiatives in the US. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & AliveCor, Inc.
US Palliative Care Market Analysis
The US Palliative care market is projected to grow from $5.5 Bn in 2022 to $8.76 Bn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The main factors driving the growth would be the aging population, growing demand for comfort and quality of life, integration with other healthcare facilities, and government support. The market is segmented by service type and by the end user. Some of the major players include Amedisys, Vitas Healthcare, Golden Living Centers, Genesis Healthcare, Home Instead, Kindred hospice, Sunrise Living Centers, and UCLA Health.
US Neurology Devices Market Analysis
The US Neurology Device Market size is at around $5.31 Bn in 2022 and is projected to reach $8.32 Bn in 2030, exhibiting a CAGR of 5.8% during the forecast period. With increasing emphasis on minimally invasive procedures and revolutionary research being focussed on Neurology diseases like ALS, Alzheimer’s disease, and traumatic Neurology impairment. Major players like Medtronic, GE Healthcare, and Siemens Healthineers are capturing a wider network of stakeholders. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
US Acne Therapeutics Market Analysis
The US acne therapeutics market is expected to witness growth from $4.21 Bn in 2022 to $6.08 Bn in 2030 with a CAGR of 4.7% for the forecasted period 2022-2030 mainly due to increased incidence of acne and demand for cosmeceuticals in the US. The market is segmented by treatment, route of administration, age group, and by distribution channel. Pfizer, Johnson & Johnson, and Padagis are some of the key market players in the US acne therapeutics market.
US Dialysis Market Analysis
The US Dialysis Market is projected to grow from $48.808 Bn in 2022 to $69.410 Bn by 2030, registering a CAGR of 4.5% during the forecast period of 2022 - 2030. The market for dialysis services in the US is anticipated to be driven by rising rates of high blood pressure and diabetes. Fresenius Medical Care company is the largest provider of dialysis services and products in the world and is the leader in the US market, with a significant market share.
US Dermatology Drugs Market Analysis
By 2030, it is anticipated that the US Dermatology drugs market will reach a value of $14 Bn from $7.14 Bn in 2022, growing at a CAGR of 8.8% during 2022-2030. The dermatology drug market in the US is dominated by a few large pharmaceutical companies such as Amgen Inc., Eli Lilly, and AbbVie. The dermatology drug market in the US is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel. The major factors affecting the US dermatology drugs market are the increasing disease burden of non-communicable diseases like cancer and the lack of healthcare facilities for cancer treatment in most areas of the US.
US Home Healthcare Market Analysis
The US home healthcare market was valued at $152.31 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.93% from 2022 to 2030 and will reach $241.48 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the cost-effectivity of home healthcare services. The market is segmented by equipment outlook and by services. Some key players in this market are McKesson Medical-Surgical, NxStage Medical (Fresenius Medical Care), Medline Industries Inc., Kindred Healthcare, Brookdale Senior Living, and Sunrise Senior Living.
US Women's Health Market Analysis
The US Women’s Health Market is projected to grow from $16.775 Bn in 2022 to $20.922 Bn by 2030, registering a CAGR of 2.80% during the forecast period of 2022 - 2030. As more women become aware of the importance of taking care of their health and the availability of new and innovative products and technologies, the demand for women's health products and services is increasing. Some key players in the US Women's Health market include Pfizer, Merck, AbbVie, Allergan, GlaxoSmithKline, Lilly, Novo Nordisk, Roche, Sanofi, Teva, Mylan, and Actavis.
US Bioinformatics Market Analysis
The US Bioinformatics market is projected to grow from $6.447 Bn in 2022 to $18.781 Bn by 2030, registering a CAGR of 14.30% during the forecast period of 2022 - 2030. The main factors driving the growth would be the increased adoption of precision medicine, the growing use of genomics in drug discovery, technological advancements, and the rising volume of biological data created. The market is segmented by technology and by application. Some of the major players include Biovia (USA), IBM Life Sciences (USA), 3rd Millennium Inc (USA), Celera Corporation (USA), Illumina Inc. (USA), Agilent Technologies (USA), Affymetrix (USA), BioWisdom Ltd.
US Breast Cancer Therapeutics Market Analysis
The US breast cancer therapeutics market size is projected to grow to $ 17.48 Bn by 2030 from $7.64 Bn in 2022, exhibiting a CAGR of 10.9% during the forecast period (2022-2030), according to the study conducted by Insights10. A lifetime diagnosis of invasive breast cancer is estimated to occur in 13% of women (1 in 8), and 3% (1 in 39) are prone to mortality, according to the American Cancer Society (US) Statistics 2020. Newer interventions in the competitive landscape are estimated to reach $4.6 Bn in revenues from major players like AstraZeneca, and Daiichii Sankyo thanks to the sizeable market demands.
US Physiotherapy Market Analysis
The US physiotherapy market size was valued at $22.34Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 3.85% from 2022 to 2030 and will reach $30.22Bn in 2030. The physiotherapy market in US is expected to see steady growth in the coming years, as an aging population, an increase in chronic diseases, greater focus on preventative care and rehabilitation after surgeries. The market is segmented by Product Type, Application Type, and End User. The major players in the US physiotherapy market are BTL Industries, EMS Physio Ltd., DJO Global, Inc., Dynatronics Corporation, Inc., Performance Health, and others.
US Patient Support Programs (PSP) Market Analysis
This report presents a strategic analysis of the US Patient Support Programs (PSP) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Patient Support Programs (PSP) Market, offering unmatched value, accuracy and expert insights.
US Women Health Diagnostic Market Analysis
This report presents a strategic analysis of the US Women Health Diagnostic Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Women Health Diagnostic Market, offering unmatched value, accuracy and expert insights.
US Pain Management Devices Market Analysis
This report presents a strategic analysis of the US Pain Management Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Pain Management Devices Market, offering unmatched value, accuracy and expert insights.
US Acne Drugs Market Analysis
This report presents a strategic analysis of the US Acne Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Acne Drugs Market, offering unmatched value, accuracy and expert insights.
US Insulin Market Analysis
This report presents a strategic analysis of the US Insulin Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Insulin Market, offering unmatched value, accuracy and expert insights.
US Liver Disease Drugs Market Analysis
This report presents a strategic analysis of the US Liver Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Liver Disease Drugs Market, offering unmatched value, accuracy and expert insights.
US Oncology Drugs Market Analysis
This report presents a strategic analysis of the US Oncology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Oncology Drugs Market, offering unmatched value, accuracy and expert insights.